To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma.
Conditions: Myelodysplastic Syndromes; Multiple Myeloma; Anemia Intervention: Drug: INCB000928 Sponsor: Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials